How the Top Medtech Companies Use AlphaSense
Medtech lies at the intersection of two of the most fast-changing and innovative industries—healthcare and technology. Innovations in this space have already contributed to vastly improved patient outcomes, better efficiency in the healthcare industry, and greater health equity. Add in a steady stream of new entrants and inventions penetrating the market, this sector is slated to grow at an accelerated pace for the foreseeable future.
For this reason, it has never been more important for medtech companies to have an airtight market research process and a proactive strategy. Without the right tool, the task of parsing through vast quantities of data, locating the right insights, and then analyzing and implementing those insights becomes herculean. Moreover, manual market research dramatically slows you down and leaves you vulnerable to human error and missed insights.
Medtech companies that want to stay on the leading edge need to be fast, proactive, informed, and adaptable. They need to be able to pivot their strategy at a moment’s notice and to avoid being blindsided by unexpected moves from competitors or regulators.
AlphaSense not only helps you stay informed on the critical insights that matter most, but empowers you to apply those insights towards specific strategic goals and analysis. Our platform speeds up your time to insight so you can increase research confidence and be more proactive in strategy-building.
Here’s how AlphaSense can help you get ahead of the competition:
Competitive Intelligence
AlphaSense surfaces all the competitive insights you need so that you can benchmark against peers, find out about any emerging competitors, generate ideas for new product development, and identify competitive risks—all in one place.
You can receive real-time alerts for 510(k) filings, competitors’ earnings reports, topical broker research, and expert call transcripts—and then access them all in one platform. And with our company recognition and Search Summaries features, you will always be first to know about any competitor updates.
Corporate Development and M&A
AlphaSense allows you to get smart on an investment target, emerging technology, intellectual property, or competitive landscape by using AI to find insights faster. Our natural language processing (NLP)-based feature theme extraction enables you to spot interesting assets within the noise by uncovering financial metrics beyond those found in standard 10-Ks or 10-Qs.
With this feature, you can also see how incumbent MedTech conglomerates are conducting their M&A strategy, including what types of companies are getting acquired or funded by whom, as well as how large healthcare firms are approaching their investments in smaller MedTech companies.
This feature is critical in the medtech space because new companies and themes are always emerging, and having access to a tool like AlphaSense keeps you in-the-know— without the information overload.
You can also use AlphaSense to gain intel on private companies. Instantly access funding round information, acquisition history, and peer comparison charts—without digging through multiple, potentially fruitless, sources.
Market Landscaping
AlphaSense ensures you never miss a critical industry update with customizable watchlists and real-time alerts for any companies or themes you are interested in.
AlphaSense also makes it simple to monitor specific subsectors of the medtech industry by searching those topics on the platform and seeing how the keywords have trended over time.
For instance, if you are interested in the TAM and growth outlooks for diabetes and its treatment areas, you can uncover key insights such as: the U.S. forecast for adults with diabetes, current existing treatments and new technologies for diabetes, the main players in the diabetes treatment space, how much healthcare systems have invested already in diabetes medtech, and so on, by simply searching “diabetes” and filtering for each content set in our platform.
Commercialization
If you are interested in commercializing a product, device, or technology, AlphaSense can help you extract market data from qualitative sources to develop TAM analyses, evaluate market opportunities to forecast sales, and develop go-to market strategies.
AlphaSense also allows you to find answers to key questions during commercialization:
- Is the concept novel and validated? To answer this, you need to evaluate the market landscape—what kinds of companies are in this space, what technologies are being used, what are the health systems using this tech, what other companies have tried bringing a similar product to market in the past, and what do experts say about similar devices or technologies?
- Has the concept cleared the regulatory and FDA requirements? For this, you can consult the regulatory documents such as 510(k) filings and European Medicines Agency documents, all housed on the AlphaSense platform.
- Is your product faster, better, or more cost-effective than competitors’? For this, you can rely on competitive signals and M&A tracking, so you can always be aware of key factors such as a huge incumbent buying a company making a similar product, health system/consumer spending in a potential target market, and what pricing and profitability look like for similar technology.
Another important consideration in commercialization is the possibility of partnering with a biopharma company or health system in order to lower cost or expand reach. For this, you must have a tool that enables you to conduct in-depth research on public and private companies.
Accelerate Your Research Process with AlphaSense
AlphaSense aggregates all the essential market research perspectives you need in one place, so you can have a complete picture of the company profiles, markets, or trends you are researching.
Combined with proprietary AI and automation functionality not found on other platforms, AlphaSense helps you dramatically increase the breadth, depth, and accuracy of your research.
Here’s what you get when you use the AlphaSense platform for your market intelligence:
Aggregated Market Research
AlphaSense houses a vast universe of over 10,000 trusted content sources, including but not limited to:
- Company documents including event transcripts, global filings, press releases, company presentations, product brochures, and ESG reports, in addition to private company documents
- Industry research from the world’s top financial research firms, including Cowen, Morgan Stanley, Bank of America, Jefferies, and JP Morgan, as well as our proprietary equity research content set Wall Street Insights that is specifically tailored for corporate clients
- Unique industry expert perspectives from customers, competitors, medical experts, doctors, and partners
- Thousands of curated news sources, trade publications, and regulatory information such as 510(k)s
Our platform not only houses all of the content you need to make rapid data-driven decisions, it also helps you cut through the noise with advanced search functionality.
Semantic Search
Instead of digging through fragmented reports and alerts, you can rely on our semantic search to ensure you never miss out on critical insights. Our AI search technology automatically recognizes what you are looking for and delivers the results that match the intent behind your query. This means you don’t have to do multiple searches to get the results you need, and you can be more confident in the comprehensiveness and accuracy of your research.
Sentiment Analysis
With AlphaSense, you can use AI-based sentiment analysis to identify, quantify, and analyze levels of emotion within text, particularly earnings calls and expert transcripts. Understanding sentiment can help you catch the subtle inflection points in language that move markets and provide early indicators of shifting corporate performance. This feature works in seconds, saving hours previously spent combing through company documents and expert transcripts for the best insights.
Generative AI
Unlike other generative AI (genAI) tools that are focused on consumer users and trained on publicly available content across the web, AlphaSense takes an entirely different approach. As a platform purpose-built to drive the world’s biggest business and financial decisions, our Smart Summaries feature leverages our 10+ years of AI tech development and draws from a curated collection of high-quality business content.
With Smart Summaries, you can glean instant earnings insights—reducing time spent on research during earnings season, quickly capture company outlook, and generate an expert-approved SWOT analysis straight from former competitors, partners, and employees. Additionally, all sources are cited, so you can verify any information by simply consulting the source documents.
Medtech Industry Insights from the AlphaSense Platform:
Analyzing Expert Transcripts: 4 Trending Conversations in MedTech
This post provides a snapshot of the most pertinent MedTech conversations available in our expert call database.
Tracking the Next M&A Deal: 16 MedTech Companies to Watch
We identified the top MedTech companies you should keep an eye on, based on recent product developments, growth, and margins.
MedTech Trends Leading the Post-Pandemic Healthcare Conversation
We dig into the rising trends that are leading the MedTech industry—robotics, digital therapeutics, telemedicine, and AI—all found in our platform.
How Leading Healthcare Companies Are Using AI to Get Ahead
Learn how life science and healthcare companies are increasingly tapping into the power of AI to conduct better, faster research and gain the competitive edge.
Fortune 500 Medical Device Company – Corporate Strategy Case Study
Read about how a Fortune 500 medical device leader uses AlphaSense to produce higher quality analysis.
Fresenius Group – Investor Relations Case Study
Read about how Fresenius Group makes IR work more efficient with AlphaSense.